In vivo CA-IX inhibition by sulfamate, sulfonamide, and coumarin inhibitors has been shown to reverse the effect of tumor acidification, leading to a delay in tumor growth, while the effects depended on the treatment schedule, administered dose, and tumor cell line [23, 30, 38, 40, 60, 61]. Here, CA9 is linked to neoplasm.